文献速递重症综合管理与镇静镇痛心脑血管急症复苏、休克与脓毒症

静脉-动脉体外膜氧合成人患者神经元特异性烯醇化酶水平研究

Neuron-Specific Enolase Levels in Adults Under Venoarterial Extracorporeal Membrane Oxygenation.
PubMed 文献 · Crit Care Explor · 2020-10-15
一句话结论VA-ECMO成人患者第3天血清NSE>25 μg/L独立关联28天死亡与90天不良功能结局,>80 μg/L对死亡和不良结局均100%特异。

第3天NSE中位数25 μg/L;校正SAPS II、ECMO前CPR和插管时SOFA评分后,第3天NSE>25 μg/L仍独立关联28天死亡(aOR 4.98,95%CI 1.86-13.32)和90天不良结局(mRS 4-6,aOR 4.63,95%CI 1.81-11.84)。第3天NSE>80 μg/L对死亡和不良功能结局预测特异性均为100%(95%CI分别为92-100%和89-100%)。行脑CT亚组中,诊断为卒中的患者NSE显著高于无卒中者。作者认为结果需多中心验证。

要点

  • VA-ECMO成人插管后第3天血清NSE>25 μg/L独立关联28天死亡(aOR 4.98,95%CI 1.86-13.32)和90天不良功能结局(aOR 4.63,95%CI 1.81-11.84)。
  • 第3天NSE>80 μg/L对28天死亡和90天不良功能结局的预测特异性均为100%(95%CI 92-100%和89-100%)。
  • 第1、3、7天NSE中位数分别为37 μg/L(26-51)、25 μg/L(19-37)、22 μg/L(17-31)。
  • 脑CT亚组中诊断为卒中的患者NSE浓度显著高于无卒中者。
  • 上述关联为单中心观察性结果,作者明确需多中心验证,不能直接作为决策阈值。

适用人群与场景

  • 法国巴黎一家大学医院两个ICU连续纳入的成人患者,因难治性心源性休克或院内心脏骤停接受VA-ECMO。

诊断标准与关键阈值

  • 不良功能结局定义为90天改良Rankin量表评分4-6分。
  • 第3天NSE按中位数25 μg/L二分类进入多变量logistic回归;第3天NSE>80 μg/L用于评估预测特异性。

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 主要终点:校正SAPS II、ECMO前CPR和插管时SOFA评分后,第3天NSE>25 μg/L独立关联28天死亡(aOR 4.98;95%CI 1.86-13.32)。
  • 关键次要终点:第3天NSE>25 μg/L独立关联90天不良功能结局(mRS 4-6,aOR 4.63;95%CI 1.81-11.84)。
  • 第3天NSE>80 μg/L对28天死亡预测特异性100%(95%CI 92-100%),对90天不良功能结局预测特异性100%(95%CI 89-100%)。
  • 亚组:行脑CT的患者中,诊断为卒中者NSE浓度显著高于无卒中者。

证据类型、等级与局限

  • 证据类型:前瞻性单中心观察性研究。

对床旁实践的改变

  • 在VA-ECMO成人中,第3天血清NSE可作为短期死亡和90天不良功能结局的风险分层参考指标,尤其>80 μg/L高度特异。
  • 该阈值来自单中心观察性研究,尚不能作为限制治疗或撤除ECMO的决策阈值,需多中心验证。
  • NSE升高时应结合脑CT等评估卒中,原文亚组显示卒中患者NSE显著更高。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

OBJECTIVES: We aimed to determine if elevations in serum neuron-specific enolase are associated with brain injury and outcomes in adults who require venoarterial extracorporeal membrane oxygenation.

DESIGN: Prospective observational study.

SETTING: Two ICUs of a university hospital, Paris, France.

PATIENTS: Consecutive adult patients treated with venoarterial extracorporeal membrane oxygenation for refractory cardiogenic shock or in-hospital refractory cardiac arrest.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: Serum sampled 1, 3, and 7 days after venoarterial extracorporeal membrane oxygenation cannulation was stored at -80°C and neuron-specific enolase concentrations were measured in batches at the end of the study. The association between neuron-specific enolase concentrations and outcomes (28-d mortality and poor outcome, defined by a score of 4-6 on the modified Rankin scale at 90 d) were explored by multivariable logistic regression, with neuron-specific enolase concentrations dichotomized according to median values. One-hundred three patients were included, of whom 26 (25%) received preextracorporeal membrane oxygenation cardiopulmonary resuscitation. Median (interquartile range) day-1, day-3, and day-7 neuron-specific enolase serum concentrations were 37 μg/L (26-51 μg/L), 25 μg/L (19-37) μg/L, and 22 μg/L (17-31 μg/L). After adjustment for Simplified Acute Physiology Score II, preextracorporeal membrane oxygenation cardiopulmonary resuscitation, and Sepsis Organ Failure Assessment score at time of cannulation, a day-3 neuron-specific enolase greater than 25 μg/L remained independently associated with 28-day mortality (adjusted odds ratio, 4.98; 95% CI, 1.86-13.32) and poor outcome at 90 days (adjusted odds ratio, 4.63; 95% CI, 1.81-11.84). A day-3 neuron-specific enolase threshold greater than 80 μg/L had a 100% specificity for prediction of both mortality (95% CI, 92-100%) and poor functional outcome (95% CI, 89-100%). In a subset of patients who underwent brain CT, neuron-specific enolase concentrations were significantly higher in patients diagnosed with stroke, as compared with those without stroke.

CONCLUSIONS: In adult patients under venoarterial extracorporeal membrane oxygenation, day-3 serum neuron-specific enolase concentrations are independently associated with short-term mortality and poor functional outcomes. These findings deserve validation in a multicenter setting.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Reuter J, Peoc'h K, Bouadma L, et al. Neuron-Specific Enolase Levels in Adults Under Venoarterial Extracorporeal Membrane Oxygenation. Crit Care Explor. 2020. PMID: 33134937. doi:10.1097/CCE.0000000000000239

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。